Abstract
1. 1. Menopausal controls not administered estrogen replacement therapy (ERT), or menopausal women taking 10 mg of tamoxifen bid had serum samples collected. 2. 2. When controls were compared to treatment, significant elevations in the TRI (triglycerides), SGOT (serum glutamic oxalacetic transaminase), SGPT (serum glutamic pyruvic transaminase) and the GGT (gamma gluteryl transferase) were found in the tamoxifen group. Liver enzymes were elevated but still within the normal range for the tamoxifen-treated group. 3. 3. The results from this study suggest that the use of tamoxifen citrate for adjuvant therapy in women with breast cancer causes no major alterations in the blood chemistry of menopausal women. The elevations observed were still within the normal ranges of menopausal women with the exception of the triglycerides.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
